Literature DB >> 11206334

Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features.

Z Suo1, J M Nesland.   

Abstract

The expression of EGFR family members was examined by immunohistochemistry in 22 phyllodes tumors, and the results were evaluated together with immunohistochemical findings for proliferation markers Ki67 and BM28, and the tumor suppressor gene product p53. Light and electron microscopy were performed in all cases. Clinical information was obtained from the medial records. We did find that expression of EG FR, c-erbB-3 and c-erbB-4 proteins could be detected in the neoplastic mesenchymal cells, and that the expression increased with increasing malignancy. Increased expressions of Ki67, BM28, p53 and EGFR family members in neoplastic cells were associated with malignancy and unfavorable clinical course. Furthermore, the expression of ER-alpha and PR in the epithelial cells of phyllodes tumors was increased compared to that in normal breast epithelium. Finally, the application of electron microscopy helped to identify a group of malignant tumors, revealing neoplastic cells with characteristic nuclear indentations, as well as an increasing number of myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11206334     DOI: 10.1080/019131200750060032

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  5 in total

1.  Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.

Authors:  G M K Tse; A K H Tsang; T C Putti; R A Scolyer; P C W Lui; B K B Law; R Z Karim; C S Lee
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 2.  Optimising preoperative diagnosis in phyllodes tumour of the breast.

Authors:  R K Jacklin; P F Ridgway; P Ziprin; V Healy; D Hadjiminas; A Darzi
Journal:  J Clin Pathol       Date:  2006-02-06       Impact factor: 3.411

Review 3.  Malignant phyllodes tumor of the breast: a systematic review.

Authors:  Germana Lissidini; Antonino Mulè; Angela Santoro; Giovanni Papa; Luca Nicosia; Enrico Cassano; Arwa Ahmed Ashoor; Paolo Veronesi; Liron Pantanowitz; Jason L Hornick; Esther Diana Rossi
Journal:  Pathologica       Date:  2022-04-13

4.  Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.

Authors:  Jorge S Reis-Filho; Fernanda Milanezi; Silvia Carvalho; Pete T Simpson; Dawn Steele; Kay Savage; Maryou B K Lambros; Emilio M Pereira; Jahn M Nesland; Sunil R Lakhani; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2005-10-25       Impact factor: 6.466

5.  MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.

Authors:  Partha Mukhopadhyay; Imayavaramban Lakshmanan; Moorthy P Ponnusamy; Subhankar Chakraborty; Maneesh Jain; Priya Pai; Lynette M Smith; Subodh M Lele; Surinder K Batra
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.